Investigator-Initiated Studies
Our commitment
Advancing science through investigator-led research
As part of our commitment to delivering innovative therapies to patients worldwide, Kyowa Kirin believes in the need to support independent research conducted by qualified independent investigators.
The scientific evidence they generate helps deepen our understanding of the benefit/risk profiles of our products, as well as allowing us to explore new opportunities to address unmet medical needs in our therapeutic areas of interest.
Aim of IIS research
At Kyowa Kirin, our goal is to fund independent research that has therapeutic breakthrough potential for patients. An IIS may be a clinical or non-clinical study for which the study sponsor requests Kyowa Kirin to provide funding, drug study, or both.
Types of eligible research
We welcome research proposals in our areas of strategic interest listed below. Any study that enhances our delivery of innovative therapies to patients worldwide and improves patient care will be considered.
Our research portfolio is focused on the following therapeutic areas: Rare conditions in the areas of Hematologic Cancers and Diseases as well as Bone and Mineral Diseases. Prioritized modalities are Advanced Therapeutic Antibodies and Hematopoietic Stem Cell Gene Therapies.
Additional consideration will be given to work in the following areas:
Oncology
- Mycosis Fungoides
- Sézary Syndrome
Rare Disease
- X-linked Hypophosphatemia
- Tumor-Induced Osteomalacia
Proposals are evaluated based on scientific merit, as well as alignment with our areas of strategic interest and availability of resources. The study sponsor assumes sole responsibility for study conduct and management, as well as all legal and regulatory requirements.
How to apply
IIS applications are accepted on a rolling submission basis and must include the following:
- Completed Study Proposal Form
- Principal Investigator’s CV
Submit Your Proposal via email of these files to: iisrequests.na@kyowakirin.com
Following a positive review of your initial submission, a full protocol and final study budget may be requested for further evaluation. Applicants will be updated on their proposal status throughout the review process. For approved protocol submissions, a written agreement and Institutional Review Board (IRB) approval are required prior to provision of support.
For questions on any steps of the process, or if you wish to discuss your study concept, please reach out to us at iisrequests.na@kyowakirin.com